123 related articles for article (PubMed ID: 38240752)
21. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
Selvarajan V; Osato M; Nah GSS; Yan J; Chung TH; Voon DC; Ito Y; Ham MF; Salto-Tellez M; Shimizu N; Choo SN; Fan S; Chng WJ; Ng SB
Leukemia; 2017 Oct; 31(10):2219-2227. PubMed ID: 28119527
[TBL] [Abstract][Full Text] [Related]
22. RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9.
Yu J; Tian X; Chang J; Liu P; Zhang R
Biomed Pharmacother; 2017 Dec; 96():782-791. PubMed ID: 29054094
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells.
Lim J; Duong T; Do N; Do P; Kim J; Kim H; El-Rifai W; Ruley HE; Jo D
Clin Cancer Res; 2013 Feb; 19(3):680-90. PubMed ID: 23230322
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer.
Zuo J; Xia J; Ju F; Yan J; Zhu A; Jin S; Shan T; Zhou H
Mol Cells; 2013 Apr; 35(4):313-9. PubMed ID: 23549984
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
[TBL] [Abstract][Full Text] [Related]
26. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
28. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.
Kim TY; Lee HJ; Hwang KS; Lee M; Kim JW; Bang YJ; Kang GH
Lab Invest; 2004 Apr; 84(4):479-84. PubMed ID: 14968123
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
30. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
[TBL] [Abstract][Full Text] [Related]
32. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
33. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
[TBL] [Abstract][Full Text] [Related]
34. Increased transcription of hsa_circ_0000644 upon RUNX family transcription factor 3 downregulation participates in the malignant development of bladder cancer.
Zhou H; Huang J; Wang F
Cell Signal; 2023 Apr; 104():110590. PubMed ID: 36627006
[TBL] [Abstract][Full Text] [Related]
35. RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer.
Liu Z; Zhang X; Xu X; Chen L; Li W; Yu H; Sun Y; Zeng J; Jia J
Eur J Cell Biol; 2014 Mar; 93(3):118-26. PubMed ID: 24636883
[TBL] [Abstract][Full Text] [Related]
36. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.
Lee SH; Jung YD; Choi YS; Lee YM
Oncotarget; 2015 Oct; 6(32):33269-78. PubMed ID: 26375442
[TBL] [Abstract][Full Text] [Related]
37. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
Su H; Fan G; Huang J; Qiu X
Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
[TBL] [Abstract][Full Text] [Related]
38. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
39. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.
Wei D; Gong W; Oh SC; Li Q; Kim WD; Wang L; Le X; Yao J; Wu TT; Huang S; Xie K
Cancer Res; 2005 Jun; 65(11):4809-16. PubMed ID: 15930301
[TBL] [Abstract][Full Text] [Related]
40. Causal relationship between the loss of RUNX3 expression and gastric cancer.
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
